Cargando…
Author Correction: Clinical Benefit of Basal Insulin Analogue Treatment in Persons with Type 2 Diabetes Inadequately Controlled on Prior Insulin Therapy: A Prospective, Noninterventional, Multicenter Study
Autores principales: | Bjekić-Macut, Jelica, Živković, Teodora Beljić, Kocić, Radivoj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104262/ https://www.ncbi.nlm.nih.gov/pubmed/29569224 http://dx.doi.org/10.1007/s13300-018-0406-4 |
Ejemplares similares
-
Clinical Benefit of Basal Insulin Analogue Treatment in Persons with Type 2 Diabetes Inadequately Controlled on Prior Insulin Therapy: A Prospective, Noninterventional, Multicenter Study
por: Bjekić-Macut, Jelica, et al.
Publicado: (2018) -
Unmet Needs in the Management of Type 2 Diabetes Mellitus Patients Starting Insulin Therapy with Basal or Premix Insulin in Routine Clinical Practice in Serbia
por: Beljić Živković, Teodora M., et al.
Publicado: (2018) -
Author Correction: Molecular engineering of safe and efficacious
oral basal insulin
por: Hubálek, Frantisek, et al.
Publicado: (2020) -
Benefits of Prior Authorizations
por: Forrester, Caroline
Publicado: (2020) -
Metabolic Perspectives for Non-classical Congenital Adrenal Hyperplasia With Relation to the Classical Form of the Disease
por: Macut, Djuro, et al.
Publicado: (2019)